J R Farndon - Concepedia

Author

J R Farndon

Also Known As

J Farndon, J R Farndon, J. FARNDON, J. Farndon, J. R. FARNDON, J. R. Farndon, J.R. Farndon, JR Farndon, JohnR. Farndon, London Nicolaides

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Bristol Royal Infirmary University of Bristol Newcastle University Cheltenham General Hospital John Radcliffe Hospital

About

J R Farndon is an author at Bristol Royal Infirmary specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	2.6K
2	Public Health	2	2	30
3	Cell Biology	2	2	598
4	Health Sciences	1	1	32
5	Biostatistics	1	1	20

J R Farndon

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER J Richard, Christopher Sainsbury, GeoffreyK. Needham, The Lancet Tumor BiologyBreast OncologyMedicineCancer GrowthPathology	1987	877
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer C Wright, S Nicholson, Brian Angus, British Journal of Cancer Advanced Breast CancerBreast OncologyMedicineCancer GrowthBreast Cancer	1992	380
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status Mitch Dowsett, J. Houghton, Cecilie Riis Iden, Annals of Oncology Her2 StatusBreast OncologyMedicineAdjuvant Tamoxifen TherapyPharmacology	2006	267
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J R C Sainsbury, A J Malcolm, David R. Appleton, Journal of Clinical Pathology Richardson ScoreBreast OncologyMedicineGrowth Factor ReceptorCancer Growth	1985	226
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER S Nicholson, P. Halcrow, J R Farndon, The Lancet Breast OncologyCancer GrowthPathologyBreast CancerMedicine	1989	218
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup S Nicholson, J Richard, Christopher Sainsbury, British Journal of Cancer Breast OncologyMedicineYear Follow-up StudyPathologyBreast Cancer	1991	166
Epidermal growth factor receptor and other oncogenes as prognostic markers. Adrian L. Harris, S Nicholson, R Sainsbury, PubMed Surgical OncologyBreast OncologyPathologyDermatologyPrognostic Markers	1992	95
The diagnosis and management of mixed arterial/venous leg ulcers in community-based clinics A. S. K. Ghauri, Isaac Nyamekye, Anthony J. Grabs, European Journal of Vascular and Endovascular Surgery Venous DiseaseVenous Disease TreatmentLower Extremity WoundVascular SurgerySurgery	1998	83
The challenge of evaluating surgical procedures. Gordon M. Stirrat, Stephen Farrow, J R Farndon, PubMed Surgical Quality ControlSurgical ProceduresMedicineClinical Trial EvaluationPatient Safety	1992	83
Influence of a specialised leg ulcer service and venous surgery on the outcome of venous leg ulcers A. S. K. Ghauri, Isaac Nyamekye, Anthony J. Grabs, European Journal of Vascular and Endovascular Surgery Venous SurgeryVenous DiseasePatient SafetyVenous Leg UlcersVascular Surgery	1998	65

Page 1